{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,6,16]],"date-time":"2023-06-16T12:00:16Z","timestamp":1686916816494},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2012,2,19]],"date-time":"2012-02-19T00:00:00Z","timestamp":1329609600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2012,7]]},"DOI":"10.1007\/s11033-012-1588-x","type":"journal-article","created":{"date-parts":[[2012,2,18]],"date-time":"2012-02-18T09:47:21Z","timestamp":1329558441000},"page":"7541-7548","source":"Crossref","is-referenced-by-count":11,"title":["\u22121131T>C and SW19 polymorphisms in APOA5 gene and lipid levels in type 2 diabetic patients"],"prefix":"10.1007","volume":"39","author":[{"given":"Mirelle O.","family":"S\u00f3ter","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karina B.","family":"Gomes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana P.","family":"Fernandes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria das G.","family":"Carvalho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Poliana S.","family":"Pinheiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adriana A.","family":"Bosco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel D. R.","family":"Silva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marinez O.","family":"Sousa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,2,19]]},"reference":[{"key":"1588_CR1","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1161\/01.CIR.0000133317.49796.0E","volume":"110","author":"American Heart Association NCEP","year":"2004","unstructured":"American Heart Association NCEP (2004) Report implications of recent clinical trials for the national cholesterol education program adult treatment panel III. Circulation 110:227\u2013239","journal-title":"Circulation"},{"key":"1588_CR2","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S0140-6736(05)66959-0","volume":"366","author":"C Baigent","year":"2005","unstructured":"Baigent C, Keech A, Kearney PM et al (2005) Cholesterol treatment trialist\u2019s (C-FF) collaborators. Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomized trials of statins. Lancet 366:267\u2013278","journal-title":"Lancet"},{"key":"1588_CR3","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1590\/S0100-879X2007000100007","volume":"40","author":"A Mendes-Lana","year":"2007","unstructured":"Mendes-Lana A, Pena GG, Freitas SN et al (2007) Apolipoprotein E polymorphism in Brazilian dyslipidemic individuals: Ouro Preto Study. Braz J Med Biol Res 40:49\u201356","journal-title":"Braz J Med Biol Res"},{"key":"1588_CR4","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1126\/science.1064852","volume":"294","author":"LA Pennacchio","year":"2001","unstructured":"Pennacchio LA, Olivier M, Hubacek JA et al (2001) An apolipoprotein influencing triglycerides in humans and mice revealed by comparative sequencing. Science 294:169\u2013173","journal-title":"Science"},{"key":"1588_CR5","doi-asserted-by":"crossref","first-page":"44512","DOI":"10.1074\/jbc.M106888200","volume":"276","author":"HN Vliet van der","year":"2001","unstructured":"van der Vliet HN, Sammels MG, Leegwater AC et al (2001) Apolipoprotein AV: A novel apolipoprotein associated with an early phase of liver regeneration. J Biol Chem 276:44512\u201344520","journal-title":"J Biol Chem"},{"key":"1588_CR6","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/S0021-9150(03)00022-4","volume":"167","author":"A Horinek","year":"2003","unstructured":"Horinek A, Vrablik M, Ceska R, Adamkova V, Poledne R, Hubacek JA (2003) 1131T>C polymorphism within the apolipoprotein AV gene in hypertriglyceridemic individuals. Atherosclerosis 167:369\u2013370","journal-title":"Atherosclerosis"},{"key":"1588_CR7","doi-asserted-by":"crossref","first-page":"2694","DOI":"10.1172\/JCI26712","volume":"115","author":"M Merkel","year":"2005","unstructured":"Merkel M, Heeren J (2005) Give me A5 for lipoprotein hydrolysis! J Clin Invest 115:2694\u20132696","journal-title":"J Clin Invest"},{"key":"1588_CR8","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1093\/clinchem\/48.9.1597","volume":"48","author":"J Ribalta","year":"2002","unstructured":"Ribalta J, Figuera L, Fernandez-Ballart J et al (2002) Newly identified apolipoprotein AV gene predisposes to high plasma triglycerides in familial combined hyperlipidemia. Clin Chem 48:1597\u20131600","journal-title":"Clin Chem"},{"key":"1588_CR9","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1007\/s00109-003-0465-4","volume":"81","author":"D Evans","year":"2003","unstructured":"Evans D, Buchwald A, Beil Fu (2003) The single nucleotide polymorphism \u22121131T>C in the apolipoprotein A5 (APOA5) gene is associated with elevated triglycerides in patients with hyperlipemia. J Mol Med 81:645\u2013654","journal-title":"J Mol Med"},{"key":"1588_CR10","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.1210\/jc.2006-1802","volume":"92","author":"R Moreno-Luna","year":"2007","unstructured":"Moreno-Luna R, Perez-Jimenez F, Marin C et al (2007) Two independent apolipoprotein A5 haplotypes module post-prandial lipoprotein metabolism in a healthy Caucasian population. J Endocrin Metab 92:2280\u20132285","journal-title":"J Endocrin Metab"},{"key":"1588_CR11","doi-asserted-by":"crossref","first-page":"3031","DOI":"10.1093\/hmg\/11.24.3031","volume":"11","author":"LA Pennacchio","year":"2002","unstructured":"Pennacchio LA, Olivier M, Hubacek RM et al (2002) Two independent apolipoprotein A5 haplotypes influence human plasma triglyceride levels. Hum Mol Genet 11:3031\u20133038","journal-title":"Hum Mol Genet"},{"key":"1588_CR12","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1161\/01.ATV.0000054194.78240.45","volume":"23","author":"LA Pennacchio","year":"2003","unstructured":"Pennacchio LA, Rubin EM (2003) Apolipoprotein A5, a newly identified agent that affects plasma triglyceride levels in humans and mice. Arteriosclerosis 23:529\u2013534","journal-title":"Arteriosclerosis"},{"key":"1588_CR13","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.atherosclerosis.2006.04.009","volume":"191","author":"N Martinelli","year":"2007","unstructured":"Martinelli N, Trabetti E, Bassi A et al (2007) The \u22121131T>C and SW19 APOA5 gene polymorphisms are associated with high levels of triglycerides and apolipoprotein C-III, but not with coronary artery disease. Atherosclerosis 191:409\u2013417","journal-title":"Atherosclerosis"},{"key":"1588_CR14","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.cca.2008.04.013","volume":"394","author":"S Charriere","year":"2008","unstructured":"Charriere S, Bernard S, Aqallal M et al (2008) Association of APOA5 \u22121131T>C and S19W gene polymorphisms with both mild hypertriglyceridemia and hyperchylomicronemia in type 2 diabetic patients. Clin Chim Acta 394:99\u2013103","journal-title":"Clin Chim Acta"},{"key":"1588_CR15","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.metabol.2004.11.009","volume":"54","author":"H Liu","year":"2005","unstructured":"Liu H, Zhang S, Lin J et al (2005) Association between DNA variants sites in the apolipoprotein A5 gene and coronary heart disease in Chinese. Metabolism 54:568\u2013572","journal-title":"Metabolism"},{"key":"1588_CR16","doi-asserted-by":"crossref","unstructured":"Brazilian Society of Cardiology (2007) IV Brazilian guidelines on dyslipidemia and guideline of atherosclerosis prevention. Arq Bras Cardiol 88:1\u2013 19, suppl. I","DOI":"10.1590\/S0066-782X2007000700001"},{"key":"1588_CR17","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1093\/clinchem\/18.6.499","volume":"18","author":"WT Friedewald","year":"1972","unstructured":"Friedewald WT, Levy RI, Fredrickson DS (1972) Estimation of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18:499\u2013502","journal-title":"Clin Chem"},{"key":"1588_CR18","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.cca.2008.05.009","volume":"395","author":"MO Sousa","year":"2008","unstructured":"Sousa MO, Al\u00eda P, Pint\u00f3 X, Corbella E, Navarro MA (2008) Interaction between APOA5 \u22121131T>C and APOE polymorphisms and their association with severe hypertriglyceridemia. Clin Chim Acta 395:68\u201371","journal-title":"Clin Chim Acta"},{"key":"1588_CR19","doi-asserted-by":"crossref","unstructured":"Brito DD, Fernandes AP, Gomes KB et al (2010) Apolipoprotein A5 \u22121131T>C polymorphism, but not APOE genotypes, increases susceptibility for dyslipidemia in children and adolescents. Mol Biol Rep 38:4381-4388","DOI":"10.1007\/s11033-010-0565-5"},{"key":"1588_CR20","doi-asserted-by":"crossref","unstructured":"De Andrade FM, Maluf SW, Schuch JB et al. (2011) The influence of the S19W SNP of the APOA5 gene on triglyceride levels in southern Brazil: Interactions with the APOE gene, sex and menopause status. Nutr Metab Cardiovasc Dis 21:548\u2013590","DOI":"10.1016\/j.numecd.2009.12.013"},{"key":"1588_CR21","unstructured":"Brazilian Society of Cardiology (2001) III Brazilian guidelines on dyslipidemia and guideline of atherosclerosis prevention. N Engl J Med 77:1\u2013 48, suppl. III"},{"key":"1588_CR22","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1126\/science.1104342","volume":"307","author":"MA Lazar","year":"2005","unstructured":"Lazar MA (2005) How obesity causes diabetes: not a tall tale. Science 307:373\u2013375","journal-title":"Science"},{"key":"1588_CR23","doi-asserted-by":"crossref","first-page":"625","DOI":"10.2143\/AC.60.6.2004935","volume":"60","author":"S Yologlu","year":"2005","unstructured":"Yologlu S, Sezgin AT, Sezgin N, Ozdemir R, Yesilada E, Topal E (2005) Determination of risk factors in obese and non-obese patients with coronary artery disease. Acta Cardiol 60:625\u2013629","journal-title":"Acta Cardiol"},{"key":"1588_CR24","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1590\/S0004-27302006000100019","volume":"50","author":"MB Gomes","year":"2006","unstructured":"Gomes MB, Neto DG, Mendon\u00e7a E, Tambasco MA, Fonseca RM, Rea RR (2006) Prevalence of overweight and obesity in patients with type 2 diabetes mellitus in Brazil: national multicenter study. Arq Bras Endocrinol Metab 50:136\u2013144","journal-title":"Arq Bras Endocrinol Metab"},{"key":"1588_CR25","doi-asserted-by":"crossref","unstructured":"Parra FC, Amado RC, Lambertucci JR, Rocha J, Antunes CM, Pena SDJ (2003) Color and genomic ancestry in Brazilians. Proc Natl Acad Sci USA 100:177\u2013 182","DOI":"10.1073\/pnas.0126614100"},{"key":"1588_CR26","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1515\/CCLM.2010.070","volume":"48","author":"CL Prochaska","year":"2010","unstructured":"Prochaska CL, Picheth G, Anghebem-Oliveira MI et al (2010) The polymorphisms \u22121131T>C and the SW19 of the APOA5 gene are not associated with coronary artery disease in the Brazilian population. Clin Chem Lab Med 48:419\u2013422","journal-title":"Clin Chem Lab Med"},{"key":"1588_CR27","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.atherosclerosis.2003.12.003","volume":"173","author":"C Szalai","year":"2004","unstructured":"Szalai C, Keszei M, Duba J et al (2004) Polymorphism in the promoter region of the apolipoprotein A5 gene is associated with an increased susceptibility for coronary artery disease. Atherosclerosis 173:109\u2013114","journal-title":"Atherosclerosis"},{"key":"1588_CR28","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0021-9150(02)00252-6","volume":"165","author":"T Nabika","year":"2002","unstructured":"Nabika T, Nasreen S, Kobayashi et al (2002) The genetic effect of apolipoprotein AV gene on the serum triglyceride level in Japanese. Atherosclerosis 165:201\u2013204","journal-title":"Atherosclerosis"},{"key":"1588_CR29","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.cca.2008.12.024","volume":"402","author":"Y Jang","year":"2009","unstructured":"Jang Y, Paik JK, Hyun JY et al (2009) The apolipoprotein A5\u20131131T>C promoter polymorphism in Koreans: association with plasma serum triglyceride concentrations, LDL particle size and coronary artery disease. Chin Chim Acta 402:83\u201387","journal-title":"Chin Chim Acta"},{"key":"1588_CR30","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1007\/s00109-003-0465-4","volume":"81","author":"D Evans","year":"2003","unstructured":"Evans D, Buchwald A, Beil FU (2003) The single nucleotide polymorphism \u22121131T>C in the apolipoprotein A5 (APOA5) gene is associated with elevated triglycerides levels in patients with hyperlipidemia. J Mol Med 81:645\u2013654","journal-title":"J Mol Med"},{"key":"1588_CR31","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.cca.2008.04.013","volume":"394","author":"S Charriere","year":"2008","unstructured":"Charriere S, Bernard S, Aqallal M et al (2008) Association of APOA5 \u22121131T>C and S19W gene polymorphisms with both mild hypertriglyceridemia and hyperchylomicronemia in type 2 diabetic patients. Clin Chim Acta 394:99\u2013103","journal-title":"Clin Chim Acta"},{"key":"1588_CR32","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.atherosclerosis.2005.05.031","volume":"185","author":"L Hsu","year":"2006","unstructured":"Hsu L, Yu LK, Chang CJ (2006) Genetic variations of apolipoprotein A5 gene are associated with the risk of coronary artery disease among Chineses in Taiwan. Atherosclerosis 185:143\u2013149","journal-title":"Atherosclerosis"},{"key":"1588_CR33","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.metabol.2004.11.009","volume":"54","author":"H Liu","year":"2005","unstructured":"Liu H, Zhang S, Lin J et al (2005) Association between DNA variants sites in the apolipoprotein A5 gene and coronary heart disease in Chinese. Metabolism 54:568\u2013572","journal-title":"Metabolism"},{"key":"1588_CR34","doi-asserted-by":"crossref","first-page":"3896","DOI":"10.1021\/bi7000533","volume":"46","author":"SK Nilsson","year":"2007","unstructured":"Nilsson SK, Lookene A, Beckstead JA (2007) Apolipoprotein A-V interaction with members of the low density lipoprotein receptor gene family. Biochemistry 46:3896\u20133904","journal-title":"Biochemistry"},{"key":"1588_CR35","doi-asserted-by":"crossref","first-page":"3039","DOI":"10.1093\/hmg\/11.24.3039","volume":"11","author":"PJ Talmud","year":"2002","unstructured":"Talmud PJ, Hawe E, Martin S et al (2002) Relative contribution of variation within the APOC3\/A4\/A5 gene cluster in determining plasma triglycerides. Hum Mol Genet 11:3039\u20133046","journal-title":"Hum Mol Genet"},{"key":"1588_CR36","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.atherosclerosis.2006.05.006","volume":"192","author":"L Qi","year":"2007","unstructured":"Qi L, Liu S, Rifai N, Hunter D, Hu FB (2007) Associations of the apolipoprotein A1\/C3\/A4\/A5 gene cluster with triglyceride and HDL cholesterol levels in women with type 2 diabetes. Atherosclerosis 192:204\u2013210","journal-title":"Atherosclerosis"},{"key":"1588_CR37","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.bbadis.2006.11.008","volume":"1772","author":"B Dorfmeister","year":"2007","unstructured":"Dorfmeister B, Cooper JA, Stephens JW et al (2007) The effect of APOA5 and APOAC3 variants on lipid parameters in European Whites, Indian Asians and Afro-Caribbeans with type 2 diabetes. Biochim Biophys Acta 1772:355\u2013356","journal-title":"Biochim Biophys Acta"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-012-1588-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11033-012-1588-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-012-1588-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,2]],"date-time":"2020-07-02T17:31:15Z","timestamp":1593711075000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11033-012-1588-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,2,19]]},"references-count":37,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2012,7]]}},"alternative-id":["1588"],"URL":"https:\/\/doi.org\/10.1007\/s11033-012-1588-x","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,2,19]]}}}